Tag | Content |
---|
EnhancerAtlas ID | HS133-16536 |
Organism | Homo sapiens |
Tissue/cell | melanoma |
Coordinate | chr2:26290160-26292190 |
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ALX3 | MA0634.1 | chr2:26291298-26291308 | TCTAATTAAA | + | 6.02 | FOXP1 | MA0481.2 | chr2:26290843-26290855 | AAGTAAACAGAA | + | 7.22 | FOXP2 | MA0593.1 | chr2:26290843-26290854 | AAGTAAACAGA | + | 6.32 | JUN(var.2) | MA0489.1 | chr2:26291638-26291652 | CTGAGTCATTTCCT | - | 6.73 | NFE2L1 | MA0089.2 | chr2:26291634-26291649 | CTTGCTGAGTCATTT | - | 6.88 | Nfe2l2 | MA0150.2 | chr2:26291636-26291651 | TGCTGAGTCATTTCC | - | 6.41 | POU6F1 | MA0628.1 | chr2:26290905-26290915 | ATTAATTAAT | + | 6.02 | POU6F1 | MA0628.1 | chr2:26290905-26290915 | ATTAATTAAT | - | 6.02 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_09566 | chr2:26289818-26294619 | CD14 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr2 | 26290784 | 26290834 | chr2 | 26291005 | 26291914 | chr2 | 26291590 | 26291772 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I026066 | chr2 | 26289807 | 26293562 |
|
Enhancer Sequence | ATCTAAAGGG CTTATTTAAA AATACATAGA TTAGTTGTAG ATATACACTG TGTAACAATG 60 AAAAGGTCAT TGTAGCAAAA GGGGTTTATA CTGTATCTGC ATACTCTATG AAAGGACCAC 120 TCATACACAT TTCCTATGTA CATATTTTTT CCATGTTTCC TACTGATCTC ACTGACAGTA 180 TTTTGATGGC TTCTTGTTGG CTGAGGAACT GGCCATGGCA CAGATGATGG ATGGGGGCAA 240 CAGCCTTGAA TATTCTCCTT CCAGCAACTG TCAACACCTG AAGGAGGGAG TTAGCTGCCT 300 GTTACCATAC TTGATATTGA CTTGGTGTCC TAAAAAGGAA AATGTCAATT GTTTCAAATT 360 TGTAAAGGGT TAAGAAAAGA GGCAGACTAC CACTAGTCAT CTTGTTAGAT TTAATCATGT 420 GTTAAAATGT GATAGCTGTT TACAATGCAC ATCTCACATG ACTACTGTGT AAGACCTTGT 480 CAGAAGTTAG AAACACCAAT TCAATGTCTG TGAAACCATC AATACTTATT TTGATGCAAC 540 TTTGTTAAAA ATGTAAAGTC TAAGACAGTA GATTTGTACA CGATGTTTGG AAACACCAAT 600 CATAAATGAA GACTTGAGGT CAAACAGACT TATGGTCACC ATACTTGCAG CAGAATTTGC 660 TGGGGGGTTG ATATATGTTC ATCAAGTAAA CAGAAACATC AAACCAGAGT AGTTCTCTAG 720 TTAGTAAAAT GAGAATAAAC AGGTTATTAA TTAATCTATT TCAGAGGATG GTCAGGTGGC 780 CTAGAGAATG CTGTCCTGGG GAAATGACAT TTATACTGCT ACATGAGATA TGATTAGAAG 840 TTAGGTAGAA GAACATCATT CCAGGCAGAG GAAGTGGGCA CAAAAAGGTC CTTAGTAAAG 900 GAGCTTTTTG AGTTCAAAGA ACTGAAAGAT GATGTGTGTT GCAAATGTGA CTTGTGAGGC 960 TAGCAGAAGC AATAGATGTT GAAGACGTGG GTTTGAGCCA GATTGTGCAG AGCCTGGTAG 1020 TCCATGCTAA GGATTCGAAT TCCATGGAAG GTTTGAGCAG GGATGTGACA TGGTTAGATT 1080 CAATTTTTAA AAGATGGTTG GCCCAGAAAA TGTGGAAAAT GGATTGGAGT TGGAATTTTC 1140 TAATTAAAGA CTTATCAAAG ATGTGTTTAA ACTCTTACTG TATACTATTT AATCTTTAAG 1200 GATTATGAGC GATTATATGT GAAAATACCT GTCAGTGACT GTGACAGTGA GCCTTTAATT 1260 TTTTTTTTGA GGTGATCTTT TTAGTGCCAA ATACATCAGA CAATCCTGAG CCAAGAGACA 1320 GAGTTCTGAT CATAGTTAAT TTGGTTTGTG AGCTTGAGCA AGTCATTTAA ACTCTGAGCC 1380 TCTTTCTTTA TCTGTAAATT GGGCGTGTTT GAGAAATGTG TGCTTAACTT TAATTGTGTT 1440 AATCGCTTAA CTCTGGTTAA CATATGGGCT GAGTCTTGCT GAGTCATTTC CTCAGACGTT 1500 GTGGGCAAGG CTTAAAACCA GCTAAGCAAA TTTAGTGATG ACACATTTTA CCTCTTCTGT 1560 AGAAGTCAGA TGAAAGAGCT GTTTCAAAAA TGTTTCACTT ATTGTTTTCA TGCAGATTAT 1620 CTCTTCGTGG GGGAGAGAAT ACAGTACACA TAGCTCAGGA ACTACTGATG CACTGCCTTC 1680 CATTTTAGTG GCAGTTTGAA TTTAAGAATT TCTAGTTTGT CTTAAGCTTT TCTGTAATCT 1740 CTCACATATA TATTCTTAAT TTCAACTGAT AATTTCTTTC TTAATGTCTA ATATAGCCTA 1800 TTTGCCCTCT GAACAGCATT GAGATGCTTT GAAATTTTAA TGCCCAAAAA GTTGGCTTTG 1860 GTAAGGTGGT TTTCATTTCT GCAGTAGAAC CATGGTTGAG GCTAATGGTC CCATCAGCAT 1920 TAGCAGGCCT TTGGCTAGTT GCACAGTAAA CTGCATGTTT CCCACTAGTA AAAGAGATAA 1980 CCCCAACAGT TTTAGGATTA ATGCTGAGTT GTAGTGTTCT TTGGGATTTA 2030
|